Bitcoin

The article highlights a structural shift in global health R&D toward resistance biology, which is directionally relevant to the longevity/biotech narrative that underpins DeSci and health-data tokens, but it carries no near-term capital allocation signal. In the current macro regime, with the total market cap at $2.91T (-2.21% 24h) and Fear & Greed at 71 (Greed), capital is still concentrated in BTC and rotating away from altcoins.

A Nature article argues that the next major advancement in tuberculosis treatment may not be a new drug, but a better understanding of how and why drug resistance emerges.